OTCMKTS:SHTDY

Sinopharm Group Competitors

$15.32
+1.14 (+8.04 %)
(As of 04/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$15.18
Now: $15.32
$15.35
50-Day Range
$11.25
MA: $12.14
$14.18
52-Week Range
$10.20
Now: $15.32
$15.35
Volume38,560 shs
Average Volume52,224 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Sinopharm Group (OTCMKTS:SHTDY) Vs. TGIFF, FFNTF, ABSCF, ABAHF, ATTBF, and ACRDF

Should you be buying SHTDY stock or one of its competitors? Companies in the sector of "medical" are considered alternatives and competitors to Sinopharm Group, including 1933 Industries (TGIFF), 4Front Ventures (FFNTF), AB Science (ABSCF), Abacus Health Products (ABAHF), Abattis Bioceuticals (ATTBF), and Acreage (ACRDF).

1933 Industries (OTCMKTS:TGIFF) and Sinopharm Group (OTCMKTS:SHTDY) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings.

Profitability

This table compares 1933 Industries and Sinopharm Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1933 IndustriesN/AN/AN/A
Sinopharm GroupN/AN/AN/A

Earnings and Valuation

This table compares 1933 Industries and Sinopharm Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1933 IndustriesN/AN/AN/AN/AN/A
Sinopharm GroupN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and target prices for 1933 Industries and Sinopharm Group, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1933 Industries01002.00
Sinopharm Group0000N/A

4Front Ventures (OTCMKTS:FFNTF) and Sinopharm Group (OTCMKTS:SHTDY) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings.

Analyst Recommendations

This is a breakdown of current ratings and target prices for 4Front Ventures and Sinopharm Group, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
4Front Ventures0000N/A
Sinopharm Group0000N/A

Earnings and Valuation

This table compares 4Front Ventures and Sinopharm Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
4Front VenturesN/AN/AN/AN/AN/A
Sinopharm GroupN/AN/AN/AN/AN/A

Profitability

This table compares 4Front Ventures and Sinopharm Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
4Front VenturesN/AN/AN/A
Sinopharm GroupN/AN/AN/A

Sinopharm Group (OTCMKTS:SHTDY) and AB Science (OTCMKTS:ABSCF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Analyst Ratings

This is a breakdown of current ratings and price targets for Sinopharm Group and AB Science, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sinopharm Group0000N/A
AB Science00103.00

Earnings & Valuation

This table compares Sinopharm Group and AB Science's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sinopharm GroupN/AN/AN/AN/AN/A
AB ScienceN/AN/AN/AN/AN/A

Profitability

This table compares Sinopharm Group and AB Science's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sinopharm GroupN/AN/AN/A
AB ScienceN/AN/AN/A

Summary

AB Science beats Sinopharm Group on 1 of the 1 factors compared between the two stocks.

Sinopharm Group (OTCMKTS:SHTDY) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Analyst Ratings

This is a breakdown of current ratings and price targets for Sinopharm Group and Abacus Health Products, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sinopharm Group0000N/A
Abacus Health Products0000N/A

Earnings & Valuation

This table compares Sinopharm Group and Abacus Health Products' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sinopharm GroupN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Profitability

This table compares Sinopharm Group and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sinopharm GroupN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Sinopharm Group (OTCMKTS:SHTDY) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Analyst Ratings

This is a breakdown of current ratings and price targets for Sinopharm Group and Abattis Bioceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sinopharm Group0000N/A
Abattis Bioceuticals0000N/A

Earnings & Valuation

This table compares Sinopharm Group and Abattis Bioceuticals' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sinopharm GroupN/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Profitability

This table compares Sinopharm Group and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sinopharm GroupN/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Sinopharm Group (OTCMKTS:SHTDY) and Acreage (OTCMKTS:ACRDF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Analyst Ratings

This is a breakdown of current ratings and price targets for Sinopharm Group and Acreage, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sinopharm Group0000N/A
Acreage00103.00

Acreage has a consensus target price of $6.00, indicating a potential upside of 133.05%. Given Acreage's higher possible upside, analysts clearly believe Acreage is more favorable than Sinopharm Group.

Earnings & Valuation

This table compares Sinopharm Group and Acreage's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sinopharm GroupN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Profitability

This table compares Sinopharm Group and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sinopharm GroupN/AN/AN/A
AcreageN/AN/AN/A

Summary

Acreage beats Sinopharm Group on 2 of the 2 factors compared between the two stocks.


Sinopharm Group Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1933 Industries logo
TGIFF
1933 Industries
0.0$0.08+0.0%$0.00N/A0.00Gap Down
4Front Ventures logo
FFNTF
4Front Ventures
0.0$1.24+4.0%$0.00N/A0.00
AB Science logo
ABSCF
AB Science
0.8$19.62+0.0%$0.00N/A0.00
ABAHF
Abacus Health Products
0.4$4.84+5.4%$0.00N/A0.00News Coverage
Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02+0.0%$0.00N/A0.00
Acreage logo
ACRDF
Acreage
1.7$2.57+0.8%$0.00N/A0.00News Coverage
Gap Down
Acreage logo
ACRGF
Acreage
1.2$2.77+0.0%$0.00N/A0.00
ACRHF
Acreage
0.6$5.43+1.3%$0.00N/A0.00News Coverage
Acusphere logo
ACUS
Acusphere
0.0$0.04+0.0%$0.00N/A0.00Gap Down
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.56+1.6%$0.00N/A0.00
ALGXY
Affinity Energy and Health
0.4$0.00+0.0%$0.00$2.05 million0.00
Affymax logo
AFFY
Affymax
0.6$0.10+20.6%$0.00N/A0.00Gap Up
AGL
agilon health
0.0$32.54+7.8%$0.00N/A0.00News Coverage
Gap Down
AgraFlora Organics International logo
AGFAF
AgraFlora Organics International
0.8$0.03+0.0%$0.00N/A0.00
AKYA
Akoya BioSciences
0.0$22.97+13.4%$0.00N/A0.00High Trading Volume
Gap Up
AKSY
Aksys
0.0$0.05+100.0%$0.00N/A0.00Gap Down
Aleafia Health logo
ALEAF
Aleafia Health
0.0$0.46+0.0%$0.00N/A0.00Gap Up
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13+0.0%$0.00N/A0.00Gap Down
Almirall logo
LBTSF
Almirall
0.5$15.00+0.0%$0.00N/A0.00
Ambu A/S logo
AMBBY
Ambu A/S
0.4$56.62+3.2%$0.00N/A0.00Decrease in Short Interest
American Green logo
ERBB
American Green
1.0$0.01+0.0%$0.00N/A0.00Gap Down
AOBI
American Oriental Bioengineering
0.4$1.50+0.0%$0.00N/A0.00
Ansell logo
ANSLF
Ansell
0.6$29.00+0.0%$0.00N/A0.00
Ansell logo
ANSLY
Ansell
0.5$118.36+1.4%$0.00N/A0.00
APHQF
Aphria
0.6$11.57+3.1%$0.00N/A0.00Gap Down
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08+0.0%$0.00N/A0.00Gap Up
Applied Biosciences logo
APPB
Applied Biosciences
0.5$0.38+42.1%$0.00N/A0.00Increase in Short Interest
Gap Down
Arjo AB (publ) logo
ARRJF
Arjo AB (publ)
0.2$7.38+0.0%$0.00N/A0.00High Trading Volume
ARNI
Arno Therapeutics
0.5$0.01+23.1%$0.00N/A0.00Gap Up
ARYX
ARYx Therapeutics
0.0$0.01+0.0%$0.00N/A0.00
Aspyra logo
APYI
Aspyra
0.0$0.13+0.0%$0.00N/A0.00
AHROQ
AtheroNova
0.0$0.01+0.0%$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06+0.0%$0.00N/A0.00
AVTI
Avitar
0.5$0.00+0.0%$0.00N/A0.00
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.61+6.6%$0.00N/A0.00
AYRSF
Ayr Strategies
1.4$21.26+0.0%$0.00N/A0.00
Ayr Wellness logo
AYRWF
Ayr Wellness
1.3$26.73+1.9%$0.00N/A0.00Gap Up
BATM Advanced Communications logo
BTAVF
BATM Advanced Communications
1.0$1.30+3.1%$0.00N/A0.00News Coverage
Gap Down
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Benchmark logo
BHCCF
Benchmark
1.0$0.79+0.0%$0.00N/A0.00
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52+0.0%$0.00N/A0.00News Coverage
Bespoke Extracts logo
BSPK
Bespoke Extracts
0.3$0.03+0.0%$0.00N/A0.00Gap Up
BOSQF
Better Plant Sciences
0.8$0.06+0.0%$0.00N/A0.00Gap Down
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06+0.0%$0.00N/A0.00News Coverage
Gap Down
BioGaia AB (publ) logo
BIOGY
BioGaia AB (publ)
0.0$25.39+0.0%$0.00N/A0.00
Biome Grow logo
BIOIF
Biome Grow
0.0$0.08+12.9%$0.00N/A0.00Gap Up
BMEA
Biomea Fusion
0.0$17.00+9.4%$0.00N/A0.00High Trading Volume
Gap Up
BIOYF
BioSyent
0.4$6.19+1.0%$0.00N/A0.00
BioTech Medics logo
BMCS
BioTech Medics
0.0$0.07+14.9%$0.00N/A0.00Gap Down
BOIRF
Boiron
0.0$41.40+0.0%$0.00N/A0.00
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.